Navigation Links
New Medical Education Program Online Helps Physicians to Make The Diagnosis of Myelodysplastic Syndrome (MDS)
Date:6/13/2013

Düsseldorf, Germany (PRWEB) June 13, 2013

University Hospital Düsseldorf and the University Cancer Center Düsseldorf announced today the launch of a new medical education training portal that helps physicians to diagnose patients with myelodysplastic syndromes. This interactive online program is available to haematologists and qualified HCPs and offers over 50 patient cases, as well as expert lectures from the world’s leading authorities on myelodysplastic syndromes, the most frequent malignant stem cell disorder in the elderly.

Myelodysplastic syndromes (MDS) are a group of conditions that occur when the blood-forming cells in the bone marrow are damaged, leading to ineffective blood production and abnormally low blood counts. Approximately 25% of patients with MDS will progress to acute myeloid leukemia (AML), a cancer of the white blood cells. People with MDS typically have low blood cell counts, which means they have very low levels of red blood cells (RBCs) (anemia), white blood cells (WBCs) (neutropenia), and/or platelets (thrombocytopenia). The incidence of MDS is thought to be between 3.5 to 12.6 per 100,000 population per year, with higher rates for people over 70 years of age.

“MDS can be difficult to diagnose because there are many different types of MDS and the signs and symptoms of MDS, if they are present, are non-specific,” says Dr. Ulrich Germing, the Vice Head of the Department of Haemotology, Oncology and Clinical Immunology at University Hospital Düsseldorf. “In addition, the list of differential diagnoses is long”. Professor Germing, who has co-authored more than 220 articles in international peer-reviewed journals, noted that “there is a clear need to educate physicians about tests that can be used to diagnose and classify MDS, as well as to predict outcomes and select appropriate treatment options.”

The new physician training portal, http://www.mdsdiagnosis.com, provides two types of interactive courses on techniques used to diagnose and score, or predict long-term outcomes in MDS. In addition to in-depth training on specific diagnostic and prognostic techniques, the website offers interactive patient profiles that allow users to follow patients and see how various MDS techniques contribute to the final diagnosis of MDS. The MDS diagnosis site is also home to lectures by key opinion leaders and MDS experts on diagnostic techniques such as blood cell morphology, fluorescent in situ hybridization (FISH), cytogenetic testing and molecular diagnostics.

“Currently, the diagnosis of MDS is often one of exclusion that is made only after ruling out other causes of ineffective blood cell production,” says Dr. John Bennett, M.D., founder of the MDS Foundation, editor of Leukemia Research, and professor emeritus, former head of medical oncology, and current attending haematopathologist at the University of Rochester Medical Center, NY, USA. “Recent advances in the use of biomarkers to diagnose MDS and identify MDS that is likely to transform to AML are changing the way we diagnose and treat patients, making this new training portal an invaluable resource for haematologists and oncologists worldwide.”

The MDS Diagnosis website (http://www.mdsdiagnosis.com) is available in four languages – English, German, French, and Spanish – and features a scientific committee comprised of leading authorities on MDS, including Doctors Germing and Bennett, as well as Dr. Francesc Sole, Professor Detlef Haase, Dr. Raphael Itzykson, Dr. Leonie Saft and Professor Dr. Arjan Van de Loosdrecht.

About the University Cancer Center Düsseldorf
The University Comprehensive Cancer Center in Dusseldorf (CCC-UTZ Universitätstumorzentrum) is supported by the commitment of the Departments and clinics of the University Hospital Dusseldorf. The organ cancer centers in the UTZ offer special expertise and a comprehensive treatment clinic.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10812398.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. David Julius Wins 2013 Dr. Paul Janssen Award for Biomedical Research
2. MedReps.com Report Shows Biotech Workers Earn the Most in Medical Sales
3. Clinovo Sponsors the First Outsourcing in Clinical Trials: Medical Devices & Diagnostics Conference, June 12-13, 2013 in Saint Paul, Minnesota
4. BioMedical Life Systems, Inc. Launches New FDA Cleared Non-Prescription TENS Device
5. Elsevier Signs Strategic Collaboration Agreement with Peoples Medical Publishing House, China
6. Alpha Source, Inc. Donates Over $320,000 in Defibrillator Equipment Parts to SE Medical Systems for Medical Missions
7. Ondine Biomedical CEO Carolyn Cross Appointed Treasurer of International Photodynamic Association
8. The EQUITY Series of Business/Medical Thrillers by Award-winning Author Rudy Mazzocchi, Continue to Climb the Charts
9. Arteriocyte announces Launch of Compass Biomedical
10. TNI BioTech, Inc. Announces Death of Senior Vice President and Chief Medical Officer, Dr. Ronald Herberman
11. Medical Concierge Travel International launches in Tandem with Leading Medical Cost Containment Company, EME International aimed at Self-Funded and Insurance Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... findings on what they believe could be a new and helpful biomarker for ... research. Click here to read it now. , Biomarkers are components ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/24/2016)... care by providing unparalleled technology to leaders of the medical imaging industry.  As such, ... to the range of products distributed by Ampronix. Photo - http://photos.prnewswire.com/prnh/20160524/371420 ... ... ... With ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
Breaking Biology News(10 mins):